N. Ciavarella

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Medicine, Pharmacology, Pharmacotherapy +10

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)

Gualtiero Palareti, Nicoletta Leali, S Coccheri et al. · The Lancet · 1996 · 1.3K citations

Medicine, Hematology, Pharmacotherapy +12

Mutations in the ER–Golgi Intermediate Compartment Protein ERGIC-53 Cause Combined Deficiency of Coagulation Factors V and VIII

William C. Nichols, Uri Seligsohn, Ariella Zivelin et al. · Cell · 1998 · 464 citations · Full text

Medicine, Genetics, Molecular Biology +12

Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the italian registry

Guido Finazzi, Vincenzo Brancaccio, Marco Moia et al. · The American Journal of Medicine · 1996 · 435 citations

Medicine, Hematology, Internal Medicine +17

Heightened Interaction between Platelets and Factor VIII/von Willebrand Factor in a New Subtype of von Willebrand's Disease

Zaverio M. Ruggeri, Franco I. Pareti, Pier Mannuccio Mannucci et al. · New England Journal of Medicine · 1980 · 373 citations

Medicine, Hematology, Pathology +17